Literature DB >> 15208531

Eradication of Helicobacter pylori: a clinical update.

Marco Romano1, Antonio Cuomo.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2004        PMID： 15208531      PMCID： PMC1140724     

Source DB:  PubMed          Journal:  MedGenMed        ISSN： 1531-0132


× No keyword cloud information.
  42 in total

Review 1.  Review article: natural history and epidemiology of Helicobacter pylori infection.

Authors:  M F Go
Journal:  Aliment Pharmacol Ther       Date:  2002-03       Impact factor: 8.171

2.  Role of Helicobacter pylori infection in gastroduodenal injury and gastric prostaglandin synthesis during long term/low dose aspirin therapy: a prospective placebo-controlled, double-blind randomized trial.

Authors:  M Feldman; B Cryer; D Mallat; M F Go
Journal:  Am J Gastroenterol       Date:  2001-06       Impact factor: 10.864

3.  Rifabutin-based 'rescue therapy' for Helicobacter pylori infected patients after failure of standard regimens.

Authors:  F Perri; V Festa; R Clemente; M Quitadamo; A Andriulli
Journal:  Aliment Pharmacol Ther       Date:  2000-03       Impact factor: 8.171

Review 4.  Molecular response of gastric epithelial cells to Helicobacter pylori-induced cell damage.

Authors:  R Zarrilli; V Ricci; M Romano
Journal:  Cell Microbiol       Date:  1999-09       Impact factor: 3.715

5.  Helicobacter pylori infection and the development of gastric cancer.

Authors:  N Uemura; S Okamoto; S Yamamoto; N Matsumura; S Yamaguchi; M Yamakido; K Taniyama; N Sasaki; R J Schlemper
Journal:  N Engl J Med       Date:  2001-09-13       Impact factor: 91.245

6.  The importance of clarithromycin dose in the management of Helicobacter pylori infection: a meta-analysis of triple therapies with a proton pump inhibitor, clarithromycin and amoxycillin or metronidazole.

Authors:  J Huang; R H Hunt
Journal:  Aliment Pharmacol Ther       Date:  1999-06       Impact factor: 8.171

7.  Helicobacter pylori eradication does not exacerbate reflux symptoms in gastroesophageal reflux disease.

Authors:  P Moayyedi; C Bardhan; L Young; M F Dixon; L Brown; A T Axon
Journal:  Gastroenterology       Date:  2001-11       Impact factor: 22.682

8.  Role of antimicrobial susceptibility testing on efficacy of triple therapy in Helicobacter pylori eradication.

Authors:  S Toracchio; L Cellini; E Di Campli; G Cappello; M G Malatesta; A Ferri; A F Ciccaglione; L Grossi; L Marzio
Journal:  Aliment Pharmacol Ther       Date:  2000-12       Impact factor: 8.171

9.  Transfer of clarithromycin to gastric juice is enhanced by omeprazole in Helicobacter pylori-infected individuals.

Authors:  J Pedrazzoli; S A Calafatti; R A Ortiz; F E Dias; M Deguer; F D Mendes; A P Bento; A A Pereira; H Piovesana; J G Ferraz; F Lerner; G de Nucci
Journal:  Scand J Gastroenterol       Date:  2001-12       Impact factor: 2.423

10.  Isolation and characterization of tetracycline-resistant clinical isolates of Helicobacter pylori.

Authors:  D H Kwon; J J Kim; M Lee; Y Yamaoka; M Kato; M S Osato; F A El-Zaatari; D Y Graham
Journal:  Antimicrob Agents Chemother       Date:  2000-11       Impact factor: 5.191
View more
  19 in total

1.  Gastropathy of old age: Helicobacter pylori infection or NSAID use.

Authors:  Mladen Davidovic; Petar Svorcan; Pavle Milanovic; Aleksandar Antovic; Dragoslav P Milosevic
Journal:  MedGenMed       Date:  2004-03-30

2.  Development of Floating-Mucoadhesive Microsphere for Site Specific Release of Metronidazole.

Authors:  Md Lutful Amin; Tajnin Ahmed; Md Abdul Mannan
Journal:  Adv Pharm Bull       Date:  2016-06-30

3.  Lactobacillus reuteri in management of Helicobacter pylori infection in dyspeptic patients: a double-blind placebo-controlled randomized clinical trial.

Authors:  Mohamed H Emara; Salem Y Mohamed; Hesham R Abdel-Aziz
Journal:  Therap Adv Gastroenterol       Date:  2014-01       Impact factor: 4.409

4.  Type 2 diabetes mellitus: A risk factor for Helicobacter pylori infection: A hospital based case-control study.

Authors:  Bikha Ram Devrajani; Syed Zulfiquar Ali Shah; Aftab Ahmed Soomro; Tarachand Devrajani
Journal:  Int J Diabetes Dev Ctries       Date:  2010-01

5.  Rifaximin Plus Levofloxacin-Based Rescue Regimen for the Eradication of Helicobacter pylori.

Authors:  Sang-Pil Yun; Han Gyung Seon; Chang Soo Ok; Kwang Ho Yoo; Min Kyung Kang; Won Hee Kim; Chang Il Kwon; Kwang Hyun Ko; Seong Gyu Hwang; Pil Won Park; Sung Pyo Hong
Journal:  Gut Liver       Date:  2012-10-18       Impact factor: 4.519

Review 6.  Gastric cancer: a comprehensive review of current and future treatment strategies.

Authors:  Rachel E Sexton; Mohammed Najeeb Al Hallak; Maria Diab; Asfar S Azmi
Journal:  Cancer Metastasis Rev       Date:  2020-09-07       Impact factor: 9.264

Review 7.  Antibiotic treatment for Helicobacter pylori: Is the end coming?

Authors:  Su Young Kim; Duck Joo Choi; Jun-Won Chung
Journal:  World J Gastrointest Pharmacol Ther       Date:  2015-11-06

Review 8.  Proton Pump Inhibitors: Are They a Real Threat to the Patient?

Authors:  Sofia Xavier; Joana Magalhães; José Cotter
Journal:  GE Port J Gastroenterol       Date:  2018-02-28

9.  Dual drug delivery system for targeting H. pylori in the stomach: preparation and in vitro characterization of amoxicillin-loaded Carbopol® nanospheres.

Authors:  Sree Harsha
Journal:  Int J Nanomedicine       Date:  2012-09-04

10.  Pharmaceutical suspension containing both immediate/sustained-release amoxicillin-loaded gelatin nanoparticles: preparation and in vitro characterization.

Authors:  Sree Harsha
Journal:  Drug Des Devel Ther       Date:  2013-09-26       Impact factor: 4.162
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.